Higher expression of topoisomerase II alpha is an independent marker of increased risk of cancer-specific death in patients with clear cell renal cell carcinoma.

Parker, Alexander S

Higher expression of topoisomerase II alpha is an independent marker of increased risk of cancer-specific death in patients with clear cell renal cell carcinoma. [electronic resource] - European urology Nov 2014 - 929-35 p. digital

Publication Type: Journal Article; Multicenter Study; Observational Study; Research Support, N.I.H., Extramural; Validation Study

1873-7560

10.1016/j.eururo.2013.12.017 doi


Adult
Aged
Aged, 80 and over
Antigens, Neoplasm--analysis
Biomarkers, Tumor--analysis
Biopsy
Carcinoma, Renal Cell--enzymology
DNA Topoisomerases, Type II--analysis
DNA-Binding Proteins--analysis
Female
Florida
Humans
Immunohistochemistry
Kaplan-Meier Estimate
Kidney Neoplasms--enzymology
Male
Middle Aged
Minnesota
Multivariate Analysis
Necrosis
Neoplasm Grading
Neoplasm Staging
Nephrectomy--adverse effects
Observer Variation
Predictive Value of Tests
Proportional Hazards Models
Registries
Reproducibility of Results
Risk Assessment
Risk Factors
Tertiary Care Centers
Time Factors
Treatment Outcome
Tumor Burden
Up-Regulation
Young Adult